Author

Patricia J. Sullivan

Children's National

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Aastha Gandhi· 1 shared Adam C. ResnickiD· 1 shared Adam KrayaiD· 1 shared Aditya LahiriiD· 1 shared Alex SickleriD· 1 shared Alice E. DavidsoniD· 1 shared Ammar S. NaqviiD· 1 shared Ana Lisa Taylor TavaresiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Aastha Gandhi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4

Ammar S. Naqvi, Patricia J. Sullivan, Ryan J. Corbett, Priyanka D. Sehgal, Karina L. Conkrite, Komal S. Rathi, Brian Ennis, Katharina E. Hayer, Bo Zhang, Miguel Brown, Daniel P. Miller, Alex Sickler, Adam Kraya, Kaleem Coleman, Joseph M. Dybas, , Jo Lynne Rokita

The paper analyzes splicing in 729 pediatric brain tumors, identifies splicing-defined subgroups, and highlights CLK1 exon 4 as an oncofetal event linked to tumor prognosis.

Neuro-Oncology Pediatrics · Jan 1, 2026Peer-reviewedGenomics

Consensus guidelines for eligibility assessment of pathogenic variants to antisense oligonucleotide treatments

David Cheerie, Margaret M. Meserve, Danique Beijer, Charu Kaiwar, Logan Newton, Ana Lisa Taylor Tavares, Aubrie Soucy, Emma Sherrill, Stefanie Leonard, Stephan Sanders, Emily J. Blake, Nour M. Elkhateeb, Aastha Gandhi, Nicole Si Yan Liang, J. Morgan, , Marlen C. Lauffer

The paper presents consensus guidelines for assessing pathogenic variants' eligibility for antisense oligonucleotide treatments, including classification criteria and considerations for different therapeutic approaches.

The American Journal of Human Genetics · Mar 26, 2025Peer-reviewedGenetic & Genomic Medicine